Improving clinical standards for the screening, diagnosis & management of osteoporosis across APAC

The Asia Pacific Consortium on Osteoporosis (APCO), comprising 39 clinical experts from 19 countries and regions across Asia Pacific (APAC), and its proposed ‘Framework’ aims to drive, and facilitate benchmarking for the provision of quality osteoporosis care across the region. According to a co-authored APCO member and Chair viewpoint article published on Monday, June 22,…

Read More

New report reveals the impact of MedTech collaborations on COVID

A series of reports released today by MTPConnect, an independent, industry-led organisation, highlight the key role the MedTech sector played in the COVID-19 pandemic response. The reports, welcomed by the Medical Technology Association of Australia (MTAA), reveal how the MedTech, biotechnology and pharmaceutical sector was impacted by COVID-19 at local and multinational levels, as well…

Read More

Aussies with CVD at higher risk from COVID-19

Tracking the incidence of COVID-19 globally, it is understood that people over the age of 60 with a pre-existing chronic condition, such as cardiovascular disease (CVD) or diabetes, are considered at greater risk to serious infection and complications.1 There has been a high prevalence of CVD in those dying from COVID-19 in Italy and China, two of the worst…

Read More

The role of strategic communications in helping to navigate unchartered COVID-19 waters

Our very own VIVA! Communications Principal and owner, Kirsten Bruce, Sydney was recently quoted in pharmaceutical industry publication, Pharma in Focus on how to engage with staff while working from home during the current COVID-19 pandemic. Today, Kirsten shares further insights on how companies should communicate both internally and externally in this challenging, unchartered landscape.…

Read More